BioRestorative Therapies, Inc. (BRTX) Earnings History
Net Loss16 years of earnings data (2010–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
BioRestorative Therapies, Inc. (BRTX) Earnings Overview
As of June 23, 2026, BioRestorative Therapies, Inc. (BRTX) reported trailing twelve-month net income of -$11M, reflecting -36.2% year-over-year growth. The company earned $-1.23 per diluted share over the past four quarters, with a net profit margin of -3959.4%.
Looking at the long-term picture, BRTX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2010.
BioRestorative Therapies, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including MESO (-$102M net income, -593.9% margin), XTNT ($2M net income, 3.7% margin), MDXG ($31M net income, 11.6% margin), BRTX has room to improve margins relative to the peer group. Compare BRTX vs MESO →
BRTX Earnings vs Peers
Earnings metrics vs comparable public companies
BRTX Historical Earnings Data (2010–2025)
16 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$14M | -58.6% | -$16M | $-1.58 | -3959.4% | -4350.1% |
| 2024 | -$9M | +13.8% | -$12M | $-1.16 | -2239.2% | -2881.6% |
| 2023 | -$10M | +21.2% | -$15M | $-2.47 | -7145.2% | -10439.5% |
| 2022 | -$13M | +70.2% | -$19M | $-3.65 | -11037.0% | -15745.8% |
| 2021 | -$44M | -293.0% | -$26M | $-37.30 | -96311.5% | -57191.0% |
| 2020 | -$11M | +23.0% | -$3M | $-28.56 | -14639.9% | -3574.1% |
| 2019 | -$15M | -17.0% | -$8M | $-3217.82 | -11267.6% | -6486.2% |
| 2018 | -$13M | -32.5% | -$8M | $-4269.37 | -11277.3% | -6889.8% |
| 2017 | -$9M | -9.4% | -$8M | $-6181.06 | -11660.1% | -10338.6% |
| 2016 | -$9M | -9.0% | -$8M | $-7356.30 | -23755.4% | -21447.6% |
| 2015 | -$8M | -41.8% | -$7M | $-9580.99 | -1259.9% | -1140.1% |
| 2014 | -$6M | +2.8% | -$5M | $-13178.33 | -1343.2% | -1183.3% |
| 2013 | -$6M | +12.0% | -$5M | $-24164.68 | -342333.0% | -282873.2% |
| 2012 | -$7M | -60.5% | -$6M | $-35143.67 | -41931.6% | -35746.1% |
| 2011 | -$4M | -80.0% | -$4M | $-26979.72 | - | - |
| 2010 | -$2M | - | -$2M | $-2115.70 | - | - |
Download Data
Export BRTX earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
16+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BRTX — Frequently Asked Questions
Quick answers to the most common questions about buying BRTX stock.
What is BRTX earnings per share (EPS)?
BRTX trailing twelve-month (TTM) diluted EPS is $-1.23, reflecting -36.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2010 to 2025 is available in the table on this page.
What is BioRestorative Therapies, Inc.'s net income?
BioRestorative Therapies, Inc. (BRTX) trailing twelve-month net income is $-11M as of 2025. Earnings declined -36.2% year-over-year.
Is BRTX profitable?
BRTX is not currently profitable on a TTM basis, reporting a net loss of $-11M. Net margin is -3959.4%. Investors should monitor for a return to profitability.
What is BRTX's earnings growth rate?
BRTX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2010 to 2025.
What are BRTX's profit margins?
BioRestorative Therapies, Inc. net profit margin is -3959.4%, operating margin is -4350.1%, and gross margin is +93.4%. Below-average margins reflect competitive or cost pressures. Return on Equity is -320.5%.
Is BRTX growing earnings?
BRTX earnings are declining — EPS fell -36.2% year-over-year. TTM net income dropped to $-11M. This contrasts with the 5-year CAGR of N/A.
What was BRTX's best earnings year?
BioRestorative Therapies, Inc.'s highest annual net income on record is $-2M, achieved in fiscal year 2010. Earnings history on this page spans 2010 to 2025 and includes all annual and quarterly figures.
What were BRTX's earnings last quarter?
BRTX's most recent reported quarter was Q1 2026. Net income was $-2M with diluted EPS of $-0.24. For a full breakdown of all quarters, see the quarterly earnings table on this page.